Magnetic resonance spectroscopy outperforms perfusion in distinguishing between pseudoprogression and disease progression in patients with glioblastoma

BACKGROUND: There is a need to establish biomarkers that distinguish between pseudoprogression (PsP) and true tumor progression in patients with glioblastoma (GBM) treated with chemoradiation. METHODS: We analyzed magnetic resonance spectroscopic imaging (MRSI) and dynamic susceptibility contrast (D...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Abtah, Mohamed E, Talati, Pratik, Fu, Melanie, Chun, Benjamin, Clark, Patrick, Peters, Anna, Ranasinghe, Anthony, He, Julian, Rapalino, Otto, Batchelor, Tracy T, Gilberto Gonzalez, R, Curry, William T, Dietrich, Jorg, Gerstner, Elizabeth R, Ratai, Eva-Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446677/
https://www.ncbi.nlm.nih.gov/pubmed/36071927
http://dx.doi.org/10.1093/noajnl/vdac128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446677/
https://www.ncbi.nlm.nih.gov/pubmed/36071927
http://dx.doi.org/10.1093/noajnl/vdac128

Ejemplares similares